$2.70-0.15|(-5.26%)
52W H: 11.8852W L: 2.51Beta: 0.44

About Kalaris Therapeutics Inc

Frequently Asked Questions

What is the 52-week range for KLRS?

The 52-week high is $11.88 and the 52-week low is $2.51.

What is the P/E ratio for KLRS?

The P/E ratio data is currently unavailable.

What is the dividend yield for KLRS?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -71.71%.

What is the Net Profit Margin?

Net Margin data is currently unavailable.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 1.79.

Analyst Recommendation Trends

Wall Street analyst consensus for KLRS over the last few months:

2026-09-01
Buy: 6
S.Buy: 6
Hold: 2
Sell: 0
2026-08-01
Buy: 6
S.Buy: 6
Hold: 2
Sell: 0
2026-07-01
Buy: 7
S.Buy: 6
Hold: 2
Sell: 0
2026-06-01
Buy: 6
S.Buy: 6
Hold: 2
Sell: 0

Related Stocks (Peers)

Companies operating in similar sectors to KLRS:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-08-27Vandekop Amy O'Leary+10,000--
2026-08-01KEATING LAURIE+18,000--
2026-07-20Bayko Liisa Ann+220,000--
2026-06-03Ferrara Napoleone+9,000--
2026-06-03Dybbs Michael+9,000--
2026-06-03Jovan-Embiricos Morana+9,000--
2026-06-03Hallal David+9,000--
2026-06-03ADAMIS ANTHONY P+9,000--
2026-06-03AKKARAJU SRINIVAS+9,000--
2026-06-03PATTERSON LEONE D+9,000--
2026-05-20AKKARAJU SRINIVAS+4,471--
2026-05-20AKKARAJU SRINIVAS+14,937--
2026-05-20AKKARAJU SRINIVAS-66,906--
2026-05-20AKKARAJU SRINIVAS+244,300$4.83$1,179,969
2026-03-20Hagen Brett R-1,915$6.72$12,869
2026-03-19Hagen Brett R+60,800--
2026-03-19Oxtoby Andrew+222,000--
2026-03-19Gall Matthew+95,000--
2026-03-19Feinsod Matthew+135,000--
2025-12-22AKKARAJU SRINIVAS+1,500,000$10$15,000,000
2025-12-18AKKARAJU SRINIVAS+479,847$10.42$5,000,006
2025-11-03Gall Matthew+235,000--